GPCR

Structure Therapeutics Inc.CIK 1888886 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for GPCR PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for GPCR

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Coll Crespo Blas	Chief Medical Officer	21	$0	$289.8K	2026-09-21
Lin Xichen	CHIEF SCIENTIFIC OFFICER	68	$0	$3.84M	2026-09-01
Berrios John Joseph	Chief Commercial Officer	4	$0	$0	2026-08-06
FMR LLC	Other	49	$0	$10.56M	2026-07-22
Waldstreicher Joanne	Director	3	$0	$0	2026-06-17
Russell Angus C.	Director	3	$0	$0	2026-06-17
TETLOW SHARON	Director	3	$0	$0	2026-06-17
WELCH DANIEL G	Director	8	$0	$0	2026-06-17
DOBMEIER ERIC	Director	3	$0	$0	2026-06-17
LOVE TED W	Director	4	$0	$0	2026-06-17
Lang Matthew	COO & GC	2	$0	$0	2026-04-15
Ma Yingli	CHIEF TECHNOLOGY OFFICER	11	$0	$0	2026-03-19
Yoon Jun	Chief Financial Officer	16	$9.0K	$0	2026-03-19
Hall Ashley	Chief Development Officer	10	$0	$0	2026-03-19
Stevens Raymond C	Chief Executive Officer	22	$60.0K	$9.77M	2026-03-19
Bach Mark Allen	Chief Medical Officer	4	$22.5K	$0	2024-03-15
BIOTECHNOLOGY VALUE FUND L P	Other	6	$0	$0	2023-05-10
FIL Ltd	Other	18	$0	$0	2023-02-07
Jung Melita Sun	Chief Business Officer	1	$15.0K	$0	2023-02-07
Farid Ramy	Director	3	$4.13M	$0	2023-02-07

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Coll Crespo Blas	CHIEF MEDICAL OFFICER	S Sale deriv	2026-09-21	2026-09-22	4,008	$36.15	$144.9K	1,157	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	C Conversion deriv	2026-09-21	2026-09-22	4,008	—	$0	5,165	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	C Conversion	2026-09-21	2026-09-22	12,024	—	$0	258,228	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	S Sale deriv	2026-09-21	2026-09-22	4,008	$36.15	$144.9K	1,157	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	C Conversion deriv	2026-09-21	2026-09-22	4,008	—	$0	5,165	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	C Conversion	2026-09-21	2026-09-22	12,024	—	$0	258,228	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	F Tax w/h	2026-09-18	2026-09-22	10,626	$11.67	$124.0K	270,252	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	F Tax w/h	2026-09-18	2026-09-22	10,626	$11.67	$124.0K	270,252	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise deriv	2026-09-01	2026-09-02	17,817	—	$0	125,081	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion deriv	2026-09-01	2026-09-02	5,939	—	$0	5,939	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-09-01	2026-09-02	1,300	$45.86	$59.6K	4,639	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-09-01	2026-09-02	4,539	$47.20	$214.2K	100	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-09-01	2026-09-02	100	$47.83	$4.8K	0	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion	2026-09-01	2026-09-02	17,817	—	$0	228,960	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise	2026-09-01	2026-09-02	17,817	$0.34	$6.1K	246,777	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-09-01	2026-09-02	100	$47.83	$4.8K	0	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-09-01	2026-09-02	4,539	$47.20	$214.3K	100	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-09-01	2026-09-02	1,300	$45.86	$59.6K	4,639	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion deriv	2026-09-01	2026-09-02	5,939	—	$0	5,939	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise deriv	2026-09-01	2026-09-02	17,817	—	$0	125,081	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion	2026-09-01	2026-09-02	17,817	—	$0	228,960	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise	2026-09-01	2026-09-02	17,817	$0.34	$6.1K	246,777	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-08-18	2026-08-19	400	$55.05	$22.0K	0	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion deriv	2026-08-18	2026-08-19	3,939	—	$0	3,939	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-08-18	2026-08-19	3,020	$53.13	$160.5K	919	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-08-18	2026-08-19	519	$54.20	$28.1K	400	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise deriv	2026-08-18	2026-08-19	11,817	—	$0	142,898	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise	2026-08-18	2026-08-19	11,817	$0.34	$4.0K	240,777	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion	2026-08-18	2026-08-19	11,817	—	$0	228,960	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-08-18	2026-08-19	400	$55.05	$22.0K	0	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-08-18	2026-08-19	519	$54.20	$28.1K	400	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-08-18	2026-08-19	3,020	$53.13	$160.5K	919	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion deriv	2026-08-18	2026-08-19	3,939	—	$0	3,939	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise deriv	2026-08-18	2026-08-19	11,817	—	$0	142,898	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion	2026-08-18	2026-08-19	11,817	—	$0	228,960	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise	2026-08-18	2026-08-19	11,817	$0.34	$4.0K	240,777	SEC↗
Berrios John Joseph	Chief Commercial Officer	A Award deriv	2026-08-06	2026-08-07	174,612	—	$0	174,612	SEC↗
Berrios John Joseph	Chief Commercial Officer	A Award	2026-08-06	2026-08-07	140,766	—	$0	140,766	SEC↗
Berrios John Joseph	Chief Commercial Officer	A Award deriv	2026-08-06	2026-08-07	174,612	—	$0	174,612	SEC↗
Berrios John Joseph	Chief Commercial Officer	A Award	2026-08-06	2026-08-07	140,766	—	$0	140,766	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise deriv	2026-08-04	2026-08-05	11,817	—	$0	154,715	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-08-04	2026-08-05	839	$50.03	$42.0K	0	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion deriv	2026-08-04	2026-08-05	3,939	—	$0	3,939	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-08-04	2026-08-05	3,100	$49.29	$152.8K	839	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion	2026-08-04	2026-08-05	11,817	—	$0	228,960	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise	2026-08-04	2026-08-05	11,817	$0.34	$4.0K	240,777	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-08-04	2026-08-05	839	$50.03	$42.0K	0	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-08-04	2026-08-05	3,100	$49.29	$152.8K	839	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion deriv	2026-08-04	2026-08-05	3,939	—	$0	3,939	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise deriv	2026-08-04	2026-08-05	11,817	—	$0	154,715	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion	2026-08-04	2026-08-05	11,817	—	$0	228,960	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise	2026-08-04	2026-08-05	11,817	$0.34	$4.0K	240,777	SEC↗
FMR LLC	10% Owner	S Sale deriv	2026-07-22	2026-07-24	1,367	$50.07	$68.4K	1,369	SEC↗
FMR LLC	10% Owner	S Sale deriv	2026-07-22	2026-07-24	16,085	$50.07	$805.4K	16,086	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise deriv	2026-07-14	2026-07-15	23,634	—	$0	166,532	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion deriv	2026-07-14	2026-07-15	7,878	—	$0	7,878	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-07-14	2026-07-15	1,600	$51.71	$82.7K	0	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-07-14	2026-07-15	6,278	$50.80	$318.9K	1,600	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion	2026-07-14	2026-07-15	23,634	—	$0	228,960	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise	2026-07-14	2026-07-15	23,634	$0.34	$8.0K	252,594	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise deriv	2026-06-25	2026-06-29	23,634	—	$0	190,166	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion deriv	2026-06-25	2026-06-29	7,878	—	$0	7,878	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2026-06-25	2026-06-29	7,878	$49.08	$386.7K	0	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion	2026-06-25	2026-06-29	23,634	—	$0	228,960	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise	2026-06-25	2026-06-29	23,634	$0.34	$8.0K	252,594	SEC↗
WELCH DANIEL G	Director	A Award deriv	2026-06-17	2026-06-18	39,453	—	$0	39,453	SEC↗
TETLOW SHARON	Director	A Award deriv	2026-06-17	2026-06-18	39,453	—	$0	39,453	SEC↗
DOBMEIER ERIC	Director	A Award deriv	2026-06-17	2026-06-18	39,453	—	$0	39,453	SEC↗
Waldstreicher Joanne	Director	A Award deriv	2026-06-17	2026-06-18	39,453	—	$0	39,453	SEC↗
LOVE TED W	Director	A Award deriv	2026-06-17	2026-06-18	39,453	—	$0	39,453	SEC↗
Russell Angus C.	Director	A Award deriv	2026-06-17	2026-06-18	39,453	—	$0	39,453	SEC↗
Lang Matthew	COO & GC	A Award deriv	2026-04-15	2026-04-23	223,776	—	$0	223,776	SEC↗
Lang Matthew	COO & GC	A Award	2026-04-15	2026-04-23	184,614	—	$0	184,614	SEC↗
FMR LLC	10% Owner	S Sale deriv	2026-04-14	2026-04-16	16,085	$55.07	$885.8K	32,171	SEC↗
FMR LLC	10% Owner	S Sale deriv	2026-04-14	2026-04-16	1,367	$55.07	$75.3K	2,736	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	A Award deriv	2026-03-19	2026-03-23	322,230	—	$0	322,230	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	A Award deriv	2026-03-19	2026-03-23	128,892	—	$0	128,892	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	A Award deriv	2026-03-19	2026-03-23	53,703	—	$0	53,703	SEC↗
Ma Yingli	CHIEF TECHNOLOGY OFFICER	A Award deriv	2026-03-19	2026-03-23	40,278	—	$0	40,278	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	A Award deriv	2026-03-19	2026-03-23	93,984	—	$0	93,984	SEC↗
Hall Ashley	Chief Development Officer	A Award deriv	2026-03-19	2026-03-23	59,073	—	$0	59,073	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	A Award	2026-03-19	2026-03-23	260,217	—	$0	1,401,593	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	A Award	2026-03-19	2026-03-23	104,085	—	$0	1,401,656	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	A Award	2026-03-19	2026-03-23	43,368	—	$0	228,960	SEC↗
Ma Yingli	CHIEF TECHNOLOGY OFFICER	A Award	2026-03-19	2026-03-23	32,526	—	$0	139,917	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	A Award	2026-03-19	2026-03-23	75,897	—	$0	280,878	SEC↗
Hall Ashley	Chief Development Officer	A Award	2026-03-19	2026-03-23	47,706	—	$0	155,187	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	F Tax w/h	2026-03-03	2026-03-05	53,454	$20.99	$1.12M	1,141,376	SEC↗
Hall Ashley	Chief Development Officer	F Tax w/h	2026-03-03	2026-03-05	4,836	$20.99	$101.5K	107,481	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	F Tax w/h	2026-03-03	2026-03-05	22,305	$20.99	$468.2K	1,297,571	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	F Tax w/h	2026-03-03	2026-03-05	18,735	$20.99	$393.2K	185,592	SEC↗
Ma Yingli	CHIEF TECHNOLOGY OFFICER	F Tax w/h	2026-03-03	2026-03-05	11,313	$20.99	$237.5K	107,391	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	F Tax w/h	2026-03-03	2026-03-05	11,826	$20.99	$248.2K	204,981	SEC↗
FMR LLC	10% Owner	S Sale deriv	2026-01-15	2026-01-20	552	$84.22	$46.5K	4,123	SEC↗
FMR LLC	10% Owner	S Sale deriv	2026-01-15	2026-01-20	465	$82.10	$38.2K	5,005	SEC↗
FMR LLC	10% Owner	S Sale deriv	2026-01-15	2026-01-20	330	$83.35	$27.5K	4,675	SEC↗
FMR LLC	10% Owner	S Sale deriv	2026-01-15	2026-01-20	20	$85.04	$1.7K	4,103	SEC↗
FMR LLC	10% Owner	S Sale deriv	2026-01-15	2026-01-20	5,477	$82.10	$449.7K	58,864	SEC↗
FMR LLC	10% Owner	S Sale deriv	2026-01-15	2026-01-20	3,880	$83.35	$323.4K	54,984	SEC↗
FMR LLC	10% Owner	S Sale deriv	2026-01-15	2026-01-20	230	$85.04	$19.6K	48,256	SEC↗
FMR LLC	10% Owner	S Sale deriv	2026-01-15	2026-01-20	6,498	$84.22	$547.3K	48,486	SEC↗
FMR LLC	10% Owner	S Sale deriv	2025-12-08	2025-12-10	1,414	$61.05	$86.3K	1,321	SEC↗
FMR LLC	10% Owner	S Sale deriv	2025-12-08	2025-12-10	709	$92.52	$65.6K	3,393	SEC↗
FMR LLC	10% Owner	S Sale deriv	2025-12-08	2025-12-10	183	$94.00	$17.2K	3,210	SEC↗
FMR LLC	10% Owner	S Sale deriv	2025-12-08	2025-12-10	16,635	$61.05	$1.02M	15,535	SEC↗
FMR LLC	10% Owner	S Sale deriv	2025-12-08	2025-12-10	5,589	$94.61	$528.8K	32,170	SEC↗
FMR LLC	10% Owner	S Sale deriv	2025-12-08	2025-12-10	2,159	$94.00	$202.9K	37,759	SEC↗
FMR LLC	10% Owner	S Sale deriv	2025-12-08	2025-12-10	8,337	$92.52	$771.3K	39,918	SEC↗
FMR LLC	10% Owner	S Sale deriv	2025-12-08	2025-12-10	1,320	$61.45	$81.1K	1	SEC↗
FMR LLC	10% Owner	S Sale deriv	2025-12-08	2025-12-10	15,535	$61.45	$954.6K	0	SEC↗
FMR LLC	10% Owner	S Sale deriv	2025-12-08	2025-12-10	475	$94.61	$44.9K	2,735	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	A Award deriv	2025-11-20	2026-03-05	824	—	$0	1,824	SEC↗
Hall Ashley	Chief Development Officer	A Award deriv	2025-11-20	2026-03-05	237	—	$0	462	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	F Tax w/h	2025-09-18	2025-09-22	8,106	$7.74	$62.7K	216,807	SEC↗
Hall Ashley	Chief Development Officer	F Tax w/h	2025-09-18	2025-09-22	6,021	$7.74	$46.6K	112,317	SEC↗
FMR LLC	10% Owner	S Sale deriv	2025-07-30	2025-08-01	26,310	$17.87	$470.2K	1,515,558	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	A Award	2025-07-01	2025-07-03	89,697	—	$0	1,210,880	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	F Tax w/h	2025-07-01	2025-07-03	16,050	$6.84	$109.8K	1,194,830	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	F Tax w/h	2025-07-01	2025-07-03	7,089	$6.84	$48.5K	1,319,876	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	A Award	2025-07-01	2025-07-03	39,606	—	$0	1,326,965	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	A Award	2025-07-01	2025-07-03	57,078	—	$0	217,173	SEC↗
Ma Yingli	CHIEF TECHNOLOGY OFFICER	A Award	2025-07-01	2025-07-03	24,459	—	$0	123,174	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	F Tax w/h	2025-07-01	2025-07-03	1,434	$6.84	$9.8K	224,913	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	A Award	2025-07-01	2025-07-03	7,992	—	$0	226,347	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	F Tax w/h	2025-07-01	2025-08-20	12,846	$6.84	$87.9K	204,327	SEC↗
Ma Yingli	CHIEF TECHNOLOGY OFFICER	F Tax w/h	2025-07-01	2025-08-20	4,470	$6.84	$30.6K	118,704	SEC↗
WELCH DANIEL G	Director	A Award deriv	2025-06-23	2025-06-25	51,804	—	$0	51,804	SEC↗
TETLOW SHARON	Director	A Award deriv	2025-06-23	2025-06-25	51,804	—	$0	51,804	SEC↗
DOBMEIER ERIC	Director	A Award deriv	2025-06-23	2025-06-25	51,804	—	$0	51,804	SEC↗
Waldstreicher Joanne	Director	A Award deriv	2025-06-23	2025-06-25	51,804	—	$0	51,804	SEC↗
LOVE TED W	Director	A Award deriv	2025-06-23	2025-06-25	51,804	—	$0	51,804	SEC↗
Russell Angus C.	Director	A Award deriv	2025-06-23	2025-06-25	42,833	—	$0	42,833	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	A Award deriv	2025-05-21	2025-07-03	1,000	—	$0	1,000	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	A Award deriv	2025-05-21	2025-07-03	831	—	$0	2,946	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	A Award deriv	2025-05-21	2025-07-03	429	—	$0	1,157	SEC↗
Hall Ashley	Chief Development Officer	A Award deriv	2025-05-20	2026-03-05	225	—	$0	225	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	A Award deriv	2025-03-15	2025-03-18	826,890	—	$0	826,890	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	A Award deriv	2025-03-15	2025-03-18	413,445	—	$0	413,445	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	A Award deriv	2025-03-15	2025-03-18	196,386	—	$0	196,386	SEC↗
Ma Yingli	CHIEF TECHNOLOGY OFFICER	A Award deriv	2025-03-15	2025-03-18	155,040	—	$0	155,040	SEC↗
Hall Ashley	Chief Development Officer	A Award deriv	2025-03-15	2025-03-18	124,032	—	$0	124,032	SEC↗
Coll Crespo Blas	Chief Medical Officer	A Award deriv	2025-03-15	2025-03-18	284,241	—	$0	284,241	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	A Award	2025-03-15	2025-03-18	340,332	—	$0	1,133,678	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	A Award	2025-03-15	2025-03-18	170,166	—	$0	1,293,299	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	A Award	2025-03-15	2025-03-18	80,829	—	$0	166,536	SEC↗
Ma Yingli	CHIEF TECHNOLOGY OFFICER	A Award	2025-03-15	2025-03-18	63,810	—	$0	100,539	SEC↗
Hall Ashley	Chief Development Officer	A Award	2025-03-15	2025-03-18	51,048	—	$0	118,338	SEC↗
Coll Crespo Blas	Chief Medical Officer	A Award	2025-03-15	2025-03-18	116,988	—	$0	219,588	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	F Tax w/h	2025-03-01	2025-07-03	12,495	$7.92	$99.0K	1,121,183	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	F Tax w/h	2025-03-01	2025-07-03	5,940	$7.92	$47.0K	1,287,359	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	F Tax w/h	2025-03-01	2025-07-03	6,441	$7.92	$51.0K	160,095	SEC↗
Ma Yingli	CHIEF TECHNOLOGY OFFICER	F Tax w/h	2025-03-01	2025-07-03	1,824	$7.92	$14.4K	98,715	SEC↗
Coll Crespo Blas	CHIEF MEDICAL OFFICER	F Tax w/h	2025-03-01	2025-07-03	1,233	$7.92	$9.8K	218,355	SEC↗
FMR LLC	10% Owner	S Sale deriv	2025-02-06	2025-02-10	41	$30.54	$1.3K	0	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	A Award deriv	2024-11-20	2025-03-18	821	—	$0	2,115	SEC↗
Coll Crespo Blas	Chief Medical Officer	A Award deriv	2024-11-20	2025-03-18	363	—	$0	728	SEC↗
Coll Crespo Blas	Chief Medical Officer	A Award deriv	2024-09-18	2024-09-20	111,000	—	$0	111,000	SEC↗
Hall Ashley	Chief Development Officer	A Award deriv	2024-09-18	2024-09-20	82,890	—	$0	82,890	SEC↗
Coll Crespo Blas	Chief Medical Officer	A Award	2024-09-18	2024-09-20	90,600	—	$0	102,600	SEC↗
Hall Ashley	Chief Development Officer	A Award	2024-09-18	2024-09-20	67,290	—	$0	67,290	SEC↗
Russell Angus C.	Director	A Award deriv	2024-08-26	2024-08-28	75,000	—	$0	75,000	SEC↗
WELCH DANIEL G	Director	A Award deriv	2024-06-25	2024-06-27	37,500	—	$0	37,500	SEC↗
TETLOW SHARON	Director	A Award deriv	2024-06-25	2024-06-27	37,500	—	$0	37,500	SEC↗
DOBMEIER ERIC	Director	A Award deriv	2024-06-25	2024-06-27	37,500	—	$0	37,500	SEC↗
Waldstreicher Joanne	Director	A Award deriv	2024-06-25	2024-06-27	37,500	—	$0	37,500	SEC↗
LOVE TED W	Director	A Award deriv	2024-06-25	2024-06-27	33,595	—	$0	33,595	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	M Exercise deriv	2024-06-12	2024-06-14	99,999	—	$0	1	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	M Exercise deriv	2024-06-12	2024-06-14	50,001	—	$0	488,766	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	M Exercise	2024-06-12	2024-06-14	99,999	$0.39	$39.0K	743,345	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	M Exercise	2024-06-12	2024-06-14	50,001	$0.48	$24.0K	793,346	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	C Conversion deriv	2024-06-10	2024-06-12	185,000	—	$0	185,000	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	S Sale deriv	2024-06-10	2024-06-12	185,000	$52.80	$9.77M	0	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	C Conversion	2024-06-10	2024-06-12	555,000	—	$0	643,346	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2024-06-03	2024-06-05	17,700	$50.00	$885.0K	0	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	S Sale deriv	2024-06-03	2024-06-05	17,700	$45.00	$796.5K	17,700	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise deriv	2024-06-03	2024-06-05	106,200	—	$0	213,800	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion deriv	2024-06-03	2024-06-05	35,400	—	$0	35,400	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	C Conversion	2024-06-03	2024-06-05	106,200	—	$0	85,707	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	M Exercise	2024-06-03	2024-06-05	106,200	$0.34	$36.1K	191,907	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	A Award deriv	2024-05-20	2025-03-18	694	—	$0	1,294	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	A Award deriv	2024-03-15	2024-03-19	335,481	—	$0	335,481	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	A Award deriv	2024-03-15	2024-03-19	148,134	—	$0	148,134	SEC↗
Bach Mark Allen	CHIEF MEDICAL OFFICER	A Award deriv	2024-03-15	2024-03-19	65,352	—	$0	65,352	SEC↗
Ma Yingli	CHIEF TECHNOLOGY OFFICER	A Award deriv	2024-03-15	2024-03-19	91,494	—	$0	91,494	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	A Award deriv	2024-03-15	2024-03-19	213,486	—	$0	213,486	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	A Award deriv	2024-03-15	2024-03-20	335,481	—	$0	335,481	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	A Award deriv	2024-03-15	2024-03-20	148,134	—	$0	148,134	SEC↗
Ma Yingli	CHIEF TECHNOLOGY OFFICER	A Award deriv	2024-03-15	2024-03-20	91,494	—	$0	91,494	SEC↗
Bach Mark Allen	CHIEF MEDICAL OFFICER	A Award deriv	2024-03-15	2024-03-20	65,352	—	$0	65,352	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	A Award deriv	2024-03-15	2024-03-20	213,486	—	$0	213,486	SEC↗
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	A Award	2024-03-15	2024-03-19	134,682	—	$0	1,198,346	SEC↗
Yoon Jun	CHIEF FINANCIAL OFFICER	A Award	2024-03-15	2024-03-19	59,469	—	$0	1,123,133	SEC↗
Bach Mark Allen	CHIEF MEDICAL OFFICER	A Award	2024-03-15	2024-03-19	26,235	—	$0	26,235	SEC↗
Ma Yingli	CHIEF TECHNOLOGY OFFICER	A Award	2024-03-15	2024-03-19	36,729	—	$0	36,729	SEC↗
Lin Xichen	CHIEF SCIENTIFIC OFFICER	A Award	2024-03-15	2024-03-19	85,707	—	$0	85,707	SEC↗
FMR LLC	10% Owner	S Sale deriv	2024-03-14	2024-03-18	21,997	$35.00	$769.9K	1,541,868	SEC↗
FMR LLC	10% Owner	S Sale deriv	2024-02-13	2024-02-15	525	$47.24	$24.8K	1,563,865	SEC↗
FMR LLC	10% Owner	J Other deriv	2023-12-22	2023-12-27	25,410	—	$0	1,564,390	SEC↗
FMR LLC	10% Owner	S Sale deriv	2023-12-05	2023-12-07	1,368	$62.46	$85.4K	2,733	SEC↗
FMR LLC	10% Owner	S Sale deriv	2023-12-05	2023-12-07	16,086	$62.46	$1.00M	32,169	SEC↗
FMR LLC	10% Owner	S Sale deriv	2023-10-18	2023-10-23	1,368	$65.64	$89.8K	4,101	SEC↗
FMR LLC	10% Owner	S Sale deriv	2023-10-18	2023-10-23	16,086	$65.64	$1.06M	48,255	SEC↗
LOVE TED W	Director	A Award deriv	2023-08-03	2023-08-04	75,000	—	$0	75,000	SEC↗
WELCH DANIEL G	Director	J Other deriv	2023-08-03	2023-08-04	205,500	$7.97	$1.64M	205,500	SEC↗
WELCH DANIEL G	Director	J Other deriv	2023-08-03	2023-08-04	205,500	$7.97	$1.64M	205,500	SEC↗
WELCH DANIEL G	Director	J Other deriv	2023-08-03	2023-08-04	411,000	$7.97	$3.28M	768,122	SEC↗
BIOTECHNOLOGY VALUE FUND L P	Other	J Other deriv	2023-05-10	2023-05-12	4,018,253	—	$0	4,018,253	SEC↗
BIOTECHNOLOGY VALUE FUND L P	Other	J Other deriv	2023-05-10	2023-05-12	2,929,660	—	$0	2,929,660	SEC↗
BIOTECHNOLOGY VALUE FUND L P	Other	J Other deriv	2023-05-10	2023-05-12	462,605	—	$0	462,605	SEC↗
BIOTECHNOLOGY VALUE FUND L P	Other	J Other	2023-05-10	2023-05-12	2,929,660	—	$0	0	SEC↗
BIOTECHNOLOGY VALUE FUND L P	Other	J Other	2023-05-10	2023-05-12	4,018,253	—	$0	0	SEC↗
BIOTECHNOLOGY VALUE FUND L P	Other	J Other	2023-05-10	2023-05-12	462,605	—	$0	0	SEC↗
FIL Ltd	Other	C Conversion deriv	2023-02-07	2023-02-09	4,013,678	—	$0	0	SEC↗
FIL Ltd	Other	C Conversion deriv	2023-02-07	2023-02-09	620,499	—	$0	0	SEC↗
FIL Ltd	Other	C Conversion deriv	2023-02-07	2023-02-09	452,867	—	$0	0	SEC↗
FIL Ltd	Other	C Conversion deriv	2023-02-07	2023-02-09	179,242	—	$0	0	SEC↗
FIL Ltd	Other	C Conversion deriv	2023-02-07	2023-02-09	71,636	—	$0	0	SEC↗
FIL Ltd	Other	C Conversion deriv	2023-02-07	2023-02-09	10,154	—	$0	0	SEC↗
FIL Ltd	Other	C Conversion deriv	2023-02-07	2023-02-09	7,411	—	$0	0	SEC↗
FIL Ltd	Other	C Conversion deriv	2023-02-07	2023-02-09	494,035	—	$0	0	SEC↗
FIL Ltd	Other	C Conversion deriv	2023-02-07	2023-02-09	624,239	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2023-02-07	2023-02-09	57,523	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2023-02-07	2023-02-09	965,115	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2023-02-07	2023-02-09	10,154	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2023-02-07	2023-02-09	414,621	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2023-02-07	2023-02-09	568,098	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2023-02-07	2023-02-09	7,411	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2023-02-07	2023-02-09	6,947	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2023-02-07	2023-02-09	214,663	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2023-02-07	2023-02-09	3,572,022	—	$0	0	SEC↗
Stevens Raymond C	Chief Executive Officer	P Buy deriv	2023-02-07	2023-02-09	4,000	$15.00	$60.0K	4,000	SEC↗
Yoon Jun	Chief Financial Officer	P Buy deriv	2023-02-07	2023-02-09	600	$15.00	$9.0K	600	SEC↗
Bach Mark Allen	Chief Medical Officer	P Buy deriv	2023-02-07	2023-02-09	1,500	$15.00	$22.5K	1,500	SEC↗
Jung Melita Sun	Chief Business Officer	P Buy deriv	2023-02-07	2023-02-09	1,000	$15.00	$15.0K	1,000	SEC↗
Farid Ramy	Director	C Conversion deriv	2023-02-07	2023-02-09	642,245	—	$0	0	SEC↗
Farid Ramy	Director	P Buy deriv	2023-02-07	2023-02-09	275,000	$15.00	$4.13M	275,000	SEC↗
WELCH DANIEL G	Director	C Conversion deriv	2023-02-07	2023-02-09	123,508	—	$0	0	SEC↗
FIL Ltd	Other	C Conversion	2023-02-07	2023-02-09	494,035	—	$0	494,035	SEC↗
FIL Ltd	Other	C Conversion	2023-02-07	2023-02-09	624,239	—	$0	624,239	SEC↗
FIL Ltd	Other	C Conversion	2023-02-07	2023-02-09	452,867	—	$0	5,087,044	SEC↗
FIL Ltd	Other	C Conversion	2023-02-07	2023-02-09	7,411	—	$0	89,201	SEC↗
FIL Ltd	Other	C Conversion	2023-02-07	2023-02-09	10,154	—	$0	81,790	SEC↗
FIL Ltd	Other	C Conversion	2023-02-07	2023-02-09	71,636	—	$0	71,636	SEC↗
FIL Ltd	Other	C Conversion	2023-02-07	2023-02-09	179,242	—	$0	5,266,286	SEC↗
FIL Ltd	Other	C Conversion	2023-02-07	2023-02-09	620,499	—	$0	4,634,177	SEC↗
FIL Ltd	Other	C Conversion	2023-02-07	2023-02-09	4,013,678	—	$0	4,013,678	SEC↗
FMR LLC	Other	C Conversion	2023-02-07	2023-02-09	57,523	—	$0	57,523	SEC↗
FMR LLC	Other	C Conversion	2023-02-07	2023-02-09	965,115	—	$0	965,115	SEC↗
FMR LLC	Other	C Conversion	2023-02-07	2023-02-09	6,947	—	$0	82,035	SEC↗
FMR LLC	Other	C Conversion	2023-02-07	2023-02-09	214,663	—	$0	4,769,404	SEC↗
FMR LLC	Other	C Conversion	2023-02-07	2023-02-09	414,621	—	$0	4,554,741	SEC↗
FMR LLC	Other	C Conversion	2023-02-07	2023-02-09	568,098	—	$0	4,140,120	SEC↗
FMR LLC	Other	C Conversion	2023-02-07	2023-02-09	10,154	—	$0	67,677	SEC↗
FMR LLC	Other	C Conversion	2023-02-07	2023-02-09	7,411	—	$0	75,088	SEC↗
FMR LLC	Other	C Conversion	2023-02-07	2023-02-09	3,572,022	—	$0	3,572,022	SEC↗
Farid Ramy	Director	C Conversion	2023-02-07	2023-02-09	642,245	—	$0	3,260,495	SEC↗
WELCH DANIEL G	Director	C Conversion	2023-02-07	2023-02-09	123,508	—	$0	123,508	SEC↗
Stevens Raymond C	Chief Executive Officer	A Award deriv	2023-02-02	2023-02-06	1,600,000	—	$0	1,600,000	SEC↗
Yoon Jun	Chief Financial Officer	A Award deriv	2023-02-02	2023-02-06	750,000	—	$0	750,000	SEC↗